Cohort Studyhigh evidence
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in Diabetes.
JCI insight·July 2, 2026·PMID 42390946
Why it mattersThis proteomic score offers a tool to refine cardiovascular risk stratification in type 2 diabetes, potentially guiding more personalized use of GLP-1 receptor agonists and other preventive therapies.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled